ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice

CompletedOBSERVATIONAL
Enrollment

1,253

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
PROCEDURE

Education

Education

Trial Locations (90)

Unknown

Boehringer Ingelheim Investigational Site 58, Baja

Boehringer Ingelheim Investigational Site 85, Békéscsaba

Boehringer Ingelheim Investigational Site 61, Budapest

Boehringer Ingelheim Investigational Site 62, Budapest

Boehringer Ingelheim Investigational Site 63, Budapest

Boehringer Ingelheim Investigational Site 66, Budapest

Boehringer Ingelheim Investigational Site 67, Budapest

Boehringer Ingelheim Investigational Site 68, Budapest

Boehringer Ingelheim Investigational Site 89, Budapest

Boehringer Ingelheim Investigational Site 90, Budapest

Boehringer Ingelheim Investigational Site 55, Cegléd

Boehringer Ingelheim Investigational Site 51, Debrecen

Boehringer Ingelheim Investigational Site 64, Dunakeszi

Boehringer Ingelheim Investigational Site 77, Dunaújváros

Boehringer Ingelheim Investigational Site 56, Edelény

Boehringer Ingelheim Investigational Site 78, Esztergom

Boehringer Ingelheim Investigational Site 86, Érd

Boehringer Ingelheim Investigational Site 60, Gyöngyös

Boehringer Ingelheim Investigational Site 52, Hajdúnánás

Boehringer Ingelheim Investigational Site 81, Kaposvár

Boehringer Ingelheim Investigational Site 54, Kecskemét

Boehringer Ingelheim Investigational Site 59, Kistokaj

Boehringer Ingelheim Investigational Site 71, Komárom

Boehringer Ingelheim Investigational Site 74, Komló

Boehringer Ingelheim Investigational Site 65, Mátraháza

Boehringer Ingelheim Investigational Site 72, Mosonmagyaróvár

Boehringer Ingelheim Investigational Site 83, Nyírbátor

Boehringer Ingelheim Investigational Site 53, Nyíregyháza

Boehringer Ingelheim Investigational Site 88, Nyíregyháza

Boehringer Ingelheim Investigational Site 73, Pécs

Boehringer Ingelheim Investigational Site 87, Szeged

Boehringer Ingelheim Investigational Site 84, Szentes

Boehringer Ingelheim Investigational Site 69, Szigetszentmiklós

Boehringer Ingelheim Investigational Site 82, Szombathely

Boehringer Ingelheim Investigational Site 76, Tapolca

Boehringer Ingelheim Investigational Site 79, Tatabánya

Boehringer Ingelheim Investigational Site 57, Tiszaújváros

Boehringer Ingelheim Investigational Site 70, Törökszentmiklós

Boehringer Ingelheim Investigational Site 75, Várpalota

Boehringer Ingelheim Investigational Site 80, Zalaegerszeg

Boehringer Ingelheim Investigational Site 29, Banská Bystrica

Boehringer Ingelheim Investigational Site 41, Bardejov

Boehringer Ingelheim Investigational Site 42, Bardejov

Boehringer Ingelheim Investigational Site 32, Bojnice

Boehringer Ingelheim Investigational Site 1, Bratislava

Boehringer Ingelheim Investigational Site 9, Bratislava

Boehringer Ingelheim Investigational Site 45, Čadca

Boehringer Ingelheim Investigational Site 28, Galanta

Boehringer Ingelheim Investigational Site 17, Gelnica

Boehringer Ingelheim Investigational Site 26, Hurbanovo

Boehringer Ingelheim Investigational Site 12, Košice

Boehringer Ingelheim Investigational Site 13, Košice

Boehringer Ingelheim Investigational Site 14, Košice

Boehringer Ingelheim Investigational Site 15, Košice

Boehringer Ingelheim Investigational Site 16, Košice

Boehringer Ingelheim Investigational Site 25, Levice

Boehringer Ingelheim Investigational Site 33, Lučenec

Boehringer Ingelheim Investigational Site 35, Lučenec

Boehringer Ingelheim Investigational Site 36, Lučenec

Boehringer Ingelheim Investigational Site 44, Martin

Boehringer Ingelheim Investigational Site 38, Michalovce

Boehringer Ingelheim Investigational Site 4, Myjava

Boehringer Ingelheim Investigational Site 22, Nitra

Boehringer Ingelheim Investigational Site 23, Nitra

Boehringer Ingelheim Investigational Site 24, Nitra

Boehringer Ingelheim Investigational Site 30, Nová Bana

Boehringer Ingelheim Investigational Site 48, Nové Mesto N. Váhom

Boehringer Ingelheim Investigational Site 19, Nové Zámky

Boehringer Ingelheim Investigational Site 20, Nové Zámky

Boehringer Ingelheim Investigational Site 21, Nové Zámky

Boehringer Ingelheim Investigational Site 5, Piešťany

Boehringer Ingelheim Investigational Site 47, Povazská Bystrica

Boehringer Ingelheim Investigational Site 39, Prešov

Boehringer Ingelheim Investigational Site 40, Prešov

Boehringer Ingelheim Investigational Site 31, Prievidza

Boehringer Ingelheim Investigational Site 11, Rimavská Sobota

Boehringer Ingelheim Investigational Site 34, Rimavská Sobota

Boehringer Ingelheim Investigational Site 10, Rožňava

Boehringer Ingelheim Investigational Site 2, Senec

Boehringer Ingelheim Investigational Site 3, Senica

Boehringer Ingelheim Investigational Site 18, Spisská Nová Ves

Boehringer Ingelheim Investigational Site 37, Stropkov

Boehringer Ingelheim Investigational Site 27, Topoľčany

Boehringer Ingelheim Investigational Site 6, Trnava

Boehringer Ingelheim Investigational Site 7, Trnava

Boehringer Ingelheim Investigational Site 8, Trnava

Boehringer Ingelheim Investigational Site 46, Trstená

Boehringer Ingelheim Investigational Site 43, Žilina

Boehringer Ingelheim Investigational Site 49, Golnik

Boehringer Ingelheim Investigational Site 50, Maribor-Pohorje

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY

NCT01388166 - ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice | Biotech Hunter | Biotech Hunter